DHR vs TSLA: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and Tesla, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
VS
Tesla, Inc. · Consumer Cyclical
$387.51
-47.6% upside to fair value
Grade D
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
TSLA |
| Current Price |
$174.04 |
$387.51 |
| Fair Value Estimate |
$197.01 |
$203.09 |
| Upside to Fair Value |
+13.2%
|
-47.6%
|
| Market Cap |
$123.2B |
$1,454.1B |
| Forward P/E |
33.4x
|
330.0x
|
| EV / EBITDA |
20.3x
|
122.9x
|
| Price / Sales |
5.0x
|
15.3x
|
| Price / FCF |
23.3x
|
233.8x
|
| Revenue Growth YoY |
+3.7%
|
-3.1%
|
| Gross Margin |
60.7%
|
18.0%
|
| Operating Margin |
21.0%
|
4.6%
|
| Return on Equity |
7.1%
|
4.8%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
4.3%
|
0.43%
|
| Analyst Consensus |
Strong Buy
|
Hold
|
Investment Thesis
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Tesla, Inc. is a leading global manufacturer of electric vehicles, energy storage, and solar products, led by CEO Elon Musk since 2008. The company has a mixed business quality profile with a strong brand and innovation leadership but faces significant challenges including declining automotive revenue, which fell nearly 10% year-over-year in 2025, and a 3.1% revenue decline in the most recent qua…
Accumulation Zones
| Metric |
DHR |
TSLA |
| Zone Low |
$147.76 |
$152.32 |
| Zone High |
$167.46 |
$172.63 |
| In Buy Zone? |
No
|
No
|